Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › NEWBURYPORT › ANNA JAQUES HOSPITAL

ANNA JAQUES HOSPITAL

NPI: 1619061769 · NEWBURYPORT, MA 01950 · Psychiatric Hospital Unit · NPI assigned 10/03/2006

$1.35M
Total Medicaid Paid
47,363
Total Claims
43,747
Beneficiaries
113
Codes Billed
2018-03
First Month
2020-11
Last Month

Provider Details

Authorized OfficialOCONNOR, DELIA (PRESIDENT & CFO)
NPI Enumeration Date10/03/2006

Related Entities

Other providers sharing the same authorized official: OCONNOR, DELIA

ProviderCityStateTotal Paid
ANNA JAQUES HOSPITAL NEWBURYPORT MA $12.84M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 18,229 $546K
2019 10,217 $283K
2020 18,917 $517K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 1,002 953 $187K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 824 789 $170K
99284 Emergency department visit for the evaluation and management, high severity 585 562 $112K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 487 465 $73K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 944 869 $48K
77063 Screening digital breast tomosynthesis, bilateral 362 362 $37K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 432 353 $36K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 367 116 $34K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 768 768 $33K
80053 Comprehensive metabolic panel 2,591 2,427 $33K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 327 314 $32K
76830 Ultrasound, transvaginal 282 282 $31K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 216 195 $31K
77067 Screening mammography, bilateral, including computer-aided detection 461 461 $30K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,381 3,871 $28K
84443 Thyroid stimulating hormone (TSH) 1,811 1,771 $27K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 740 730 $24K
71046 Radiologic examination, chest; 2 views 614 593 $24K
83036 Hemoglobin; glycosylated (A1C) 1,190 1,185 $21K
99441 138 132 $21K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 740 730 $20K
88305 Level IV - Surgical pathology, gross and microscopic examination 346 346 $17K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 124 107 $17K
74177 Computed tomography, abdomen and pelvis; with contrast material 149 149 $16K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 251 75 $15K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 331 309 $14K
80048 Basic metabolic panel (calcium, ionized) 1,529 1,397 $14K
80061 Lipid panel 2,328 2,319 $14K
99219 16 13 $12K
86803 468 466 $12K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 61 59 $10K
87480 381 365 $8K
96361 Intravenous infusion, hydration; each additional hour 30 28 $8K
80050 General health panel 500 498 $8K
87510 381 365 $7K
87086 Culture, bacterial; quantitative colony count, urine 977 920 $7K
87660 381 365 $7K
70450 Computed tomography, head or brain; without contrast material 54 53 $6K
82728 255 251 $6K
84439 602 591 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 79 77 $5K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 25 25 $5K
82607 313 310 $4K
99282 Emergency department visit for the evaluation and management, low to moderate severity 24 24 $4K
76819 Fetal biophysical profile; without non-stress testing 59 38 $4K
80076 868 840 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited 44 44 $3K
76801 12 12 $3K
36415 Collection of venous blood by venipuncture 7,547 6,534 $3K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 32 27 $3K
84484 300 252 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 108 108 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 28 26 $2K
81003 1,170 1,113 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 13 12 $2K
87340 165 165 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 588 516 $2K
83690 401 377 $2K
83550 123 119 $2K
80081 25 25 $2K
86618 116 114 $2K
86706 146 146 $2K
82043 299 297 $2K
87070 244 232 $2K
84481 94 94 $2K
S0020 Injection, bupivicaine hydrochloride, 30 ml 18 18 $1K
83540 196 192 $1K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12 12 $1K
81001 514 485 $1K
86704 87 87 $1K
87522 Neg quan hep c or qual rna 27 27 $1K
84702 93 69 $1K
86709 56 56 $1K
97161 12 12 $1K
81025 268 257 $1K
99217 12 12 $900.00
83735 160 147 $850.91
87186 100 96 $836.88
82746 52 52 $802.47
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 437 415 $797.00
85651 226 220 $760.54
94761 146 132 $720.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 28 28 $656.88
87077 66 64 $589.60
86038 42 41 $570.78
96375 Therapeutic injection; each additional sequential IV push 236 209 $550.00
83520 13 13 $538.35
86140 106 103 $497.14
85610 145 122 $466.24
J2704 Injection, propofol, 10 mg 557 525 $378.04
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 541 487 $306.89
82950 31 31 $302.79
G0103 Prostate cancer screening; prostate specific antigen test (psa) 96 96 $268.71
J3010 Injection, fentanyl citrate, 0.1 mg 341 246 $248.04
86592 51 51 $212.04
82565 49 39 $172.72
86430 25 25 $159.50
J2250 Injection, midazolam hydrochloride, per 1 mg 185 175 $118.33
J1885 Injection, ketorolac tromethamine, per 15 mg 149 139 $110.36
J2405 Injection, ondansetron hydrochloride, per 1 mg 384 339 $94.63
82570 17 12 $89.68
86850 24 24 $86.64
J1100 Injection, dexamethasone sodium phosphate, 1 mg 97 88 $86.64
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 56 36 $69.00
86900 26 26 $62.86
86901 26 26 $62.86
J0690 Injection, cefazolin sodium, 500 mg 26 24 $54.95
82948 35 26 $35.74
84703 14 14 $15.50
J7030 Infusion, normal saline solution , 1000 cc 243 239 $0.00
84520 30 25 $0.00
94760 45 41 $0.00
71045 Radiologic examination, chest; single view 14 13 $0.00